CAS: 936446-61-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NRC-2694 REF: AN-AG01EO8CCAS: 936446-61-6 | 97% | 177.00 €~297.00 € | Mon 08 Jul 24 |
 | NRC-2694 REF: TM-T16343CAS: 936446-61-6 | 99.38% | 158.00 €~1,551.00 € | Mon 15 Jul 24 |
 | NRC-2694 REF: 3D-LMB44661CAS: 936446-61-6 | Min. 95% | To inquire | Mon 19 Aug 24 |
NRC-2694
CAS:936446-61-6
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and …
Formula:
C24H26N4O3
Purity:
99.38%
Color and Shape:
Solid
Molecular weight:
418.49
Ref: TM-T16343
| 1mg | 158.00 € | ||
| 5mg | 307.00 € | ||
| 10mg | 525.00 € | ||
| 25mg | 828.00 € | ||
| 50mg | 1,147.00 € | ||
| 100mg | 1,551.00 € | ||
| 1ml*10 (DMSO) | 339.00 € |
Estimated delivery in United States, on Monday 15 Jul 2024
NRC-2694
CAS:936446-61-6
NRC-2694 is a novel anilino-based oral solid formulation for the treatment of bladder cancer. NRC-2694 …
Formula:
C24H26N4O3
Purity:
Min. 95%
Molecular weight:
418.49 g/mol
Ref: 3D-LMB44661
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 19 Aug 2024
